{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:26:36Z","timestamp":1748867196931},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11938-018-0172-4","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T05:57:20Z","timestamp":1519624640000},"page":"86-100","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Updates on Women\u2019s Health Issues in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Nirupama","family":"Bonthala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunanda","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"issue":"6","key":"172_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","volume":"15","author":"R Shivashankar","year":"2017","unstructured":"\u2022 Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017;15(6):857. This article provides the most up to date incidence and prevalence of UC and IBD.\u201363. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.039 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"172_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46\u201354. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.001 .","journal-title":"Gastroenterology"},{"key":"172_CR3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/ibd.20545","volume":"14","author":"RD Johnston","year":"2008","unstructured":"Johnston RD, Logan RF. What is the peak age for onset of IBD? Inflamm Bowel Dis. 2008;14:S4\u20135. https:\/\/doi.org\/10.1002\/ibd.20545 .","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"172_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1203\/00006450-200302000-00002","volume":"53","author":"B Ballinger","year":"2003","unstructured":"Ballinger B, Savage MO, Sanderson IR. Delayed puberty associated with inflammatory bowel disease. Pediatr Res. 2003;53(2):205\u201310. https:\/\/doi.org\/10.1203\/00006450-200302000-00002 .","journal-title":"Pediatr Res"},{"issue":"6939","key":"172_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/bmj.308.6939.1259","volume":"308","author":"A Ferguson","year":"1994","unstructured":"Ferguson A, Sedgwick DM. Juvenile onset in inflammatory bowel disease: height and body mass index in adult life. Br Med J. 1994;308(6939):1259\u201363. https:\/\/doi.org\/10.1136\/bmj.308.6939.1259 .","journal-title":"Br Med J"},{"issue":"1","key":"172_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0950-3528(06)80020-5","volume":"8","author":"CE Brain","year":"1994","unstructured":"Brain CE, Savage MO. Growth and puberty in chronic in inflammatory bowel disease. Baillie\u2019re\u2019s clinical Gastroenterology. 1994;8(1):83\u2013100.","journal-title":"Baillie\u2019re\u2019s clinical Gastroenterology"},{"issue":"6","key":"172_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ibd.20378","volume":"14","author":"R Heuschkel","year":"2008","unstructured":"Heuschkel R, Salvestrini C, Beattie RM, et al. Guidelines for the management of growth failure in childhood in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(6):839\u201349. https:\/\/doi.org\/10.1002\/ibd.20378 .","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"172_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1471-0528.1998.tb10014.x","volume":"105","author":"J Moore","year":"1998","unstructured":"Moore J, Barlow D, Jewell D, Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol. 1998;105(12):1322\u20135. https:\/\/doi.org\/10.1111\/j.1471-0528.1998.tb10014.x .","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"172_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/1751-2980.12247","volume":"16","author":"S Bharadwaj","year":"2015","unstructured":"\u2022 Bharadwaj S, Kulkarni G, Shen B. Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery. J Dig Dis. 2015;16(5):245\u201355. This article discussed cyclical GI symptoms with menstrual cycle. https:\/\/doi.org\/10.1111\/1751-2980.12247 .","journal-title":"J Dig Dis"},{"issue":"10","key":"172_CR10","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/j.1572-0241.1998.540_i.x","volume":"93","author":"SV Kane","year":"1998","unstructured":"Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93(10):1867\u201372. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.540_i.x .","journal-title":"Am J Gastroenterol"},{"key":"172_CR11","unstructured":"Parlak E, Da\u011fli U, Alkim C, Di\u015fibeyaz S, Tun\u00e7 B, Ulker A, et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003;14(4):250\u20136."},{"issue":"10","key":"172_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/MIB.0000000000000134","volume":"20","author":"LM Gawron","year":"2014","unstructured":"\u2022 Gawron LM, Goldberger A, Gawron AJ, Hammond C, Keefer L. The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(10):1729\u201333. Improvement in cyclical IBD symptoms was reported in 19% of women using estrogen-based therapy and 47% of women using a levonorgestrel intrauterine device. https:\/\/doi.org\/10.1097\/MIB.0000000000000134 .","journal-title":"Inflamm Bowel Dis"},{"key":"172_CR13","doi-asserted-by":"publisher","unstructured":"\u2022 Saha S, Zhao YQ, Shah SA, Esposti SD, Lidofsky S, Salih S, et al. Menstrual cycle changes in women with in inflammatory bowel disease: a study from the ocean state Crohn\u2019s and colitis area registry. Inflamm Bowel Dis. 2014;20(3):534\u201340. Up to 25% of females experienced changes in their menstrual cycle the year prior to their diagnosis of IBD. https:\/\/doi.org\/10.1097\/01.MIB.0000441347.94451.cf .","DOI":"10.1097\/01.MIB.0000441347.94451.cf"},{"issue":"1","key":"172_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5009\/gnl.2013.7.1.51","volume":"7","author":"SM Lim","year":"2013","unstructured":"Lim SM, Nam CM, Kimetal YN. The effect of the menstrual cycle on inflammatory bowel disease: a prospective study. Gut and Liver. 2013;7(1):51\u20137. https:\/\/doi.org\/10.5009\/gnl.2013.7.1.51 .","journal-title":"Gut and Liver"},{"issue":"12","key":"172_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","volume":"5","author":"MD Kappelman","year":"2007","unstructured":"Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2007.07.012 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"172_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ibd.20839","volume":"15","author":"R Mountifield","year":"2009","unstructured":"Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009;15(5):720\u20135. https:\/\/doi.org\/10.1002\/ibd.20839 .","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"172_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.crohns.2012.09.010","volume":"7","author":"CP Sellinger","year":"2013","unstructured":"Sellinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7(6):206\u201313.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"172_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ibd.20082","volume":"13","author":"SR Marri","year":"2007","unstructured":"Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(5):591\u20139. https:\/\/doi.org\/10.1002\/ibd.20082 .","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"172_CR19","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1136\/gut.2005.078097","volume":"55","author":"U Mahadevan","year":"2006","unstructured":"Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006;55(8):1198\u2013206. https:\/\/doi.org\/10.1136\/gut.2005.078097 .","journal-title":"Gut"},{"issue":"8","key":"172_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/apt.12478","volume":"38","author":"N Tavernier","year":"2013","unstructured":"Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):847\u201353. https:\/\/doi.org\/10.1111\/apt.12478 .","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"172_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/gut.21.6.469","volume":"21","author":"CP Willoughby","year":"1980","unstructured":"Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut. 1980;21(6):469\u201374. https:\/\/doi.org\/10.1136\/gut.21.6.469 .","journal-title":"Gut"},{"issue":"2","key":"172_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0020-7292(97)00088-X","volume":"58","author":"M Hudson","year":"1997","unstructured":"Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NAG. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58(2):229\u201337. https:\/\/doi.org\/10.1016\/S0020-7292(97)00088-X .","journal-title":"Int J Gynaecol Obstet"},{"key":"172_CR23","doi-asserted-by":"publisher","unstructured":"Fr\u00e9our T, Miossec C, Bach-Ngohou K, Dejoie T, Flamant M, Maillard O, et al. Ovarian reserve in young women of reproductive age with Crohn's disease. Inflamm Bowel Dis. 2012;18(8):1515\u201322. https:\/\/doi.org\/10.1002\/ibd.21872 .","DOI":"10.1002\/ibd.21872"},{"key":"172_CR24","doi-asserted-by":"publisher","unstructured":"Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon rectum. 2007;50(8):1128\u201338. https:\/\/doi.org\/10.1007\/s10350-007-0240-7 .","DOI":"10.1007\/s10350-007-0240-7"},{"issue":"12","key":"172_CR25","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1097\/MIB.0000000000000171","volume":"20","author":"S Bharadwaj","year":"2014","unstructured":"Bharadwaj S, Philpott JR, Barber MD, Graff l, Shen B. Women\u2019s health issues after ileal pouch surgery. Inflamm Bowel Dis. 2014;20(12):2470\u201382. https:\/\/doi.org\/10.1097\/MIB.0000000000000171 .","journal-title":"Inflamm Bowel Dis"},{"key":"172_CR26","doi-asserted-by":"publisher","unstructured":"\u2022 Pabby V, Oza SS, Dodge LE, Hacker MR, Moragianni VA, Correia K, et al. In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastamosis. Am J Gastroenterol. 2015;110(6):792\u20137. This study demonstrated that live birth rates after IVF in women with IPAAs were comparable to women with UC without IPAA and women without UC. https:\/\/doi.org\/10.1038\/ajg.2014.400 .","DOI":"10.1038\/ajg.2014.400"},{"issue":"4","key":"172_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2036.2007.03397.x","volume":"26","author":"ZS Heetun","year":"2007","unstructured":"Heetun ZS, Byrnes C, Neary P, et al. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26(4):513\u201333. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03397.x .","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"172_CR28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3109\/00365528809090175","volume":"23","author":"PM Zelissen","year":"1988","unstructured":"Zelissen PM, van Hattum J, Poen H, et al. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol. 1988;23(9):1100\u20134. https:\/\/doi.org\/10.3109\/00365528809090175 .","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"172_CR29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/gut.25.10.1078","volume":"25","author":"C O'Mor\u00e1in","year":"1984","unstructured":"O'Mor\u00e1in C, Smethurst P, Dor\u00e9 CJ, et al. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut. 1984;25(10):1078\u201384. https:\/\/doi.org\/10.1136\/gut.25.10.1078 .","journal-title":"Gut"},{"issue":"8137","key":"172_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(79)90292-7","volume":"2","author":"AJ Levi","year":"1979","unstructured":"Levi AJ, Fisher AM, Hughes L, Hendry WF. Male infertility due to sulphasalazine. Lancet. 1979;2(8137):276\u20138.","journal-title":"Lancet"},{"issue":"4","key":"172_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MIB.0000000000001064","volume":"23","author":"A Grosen","year":"2017","unstructured":"Grosen A, Kelsen J, Hvas CL, Bellaguarda E, Hanauer SB. The influence of methotrexate treatment on male fertility and pregnancy outcome after paternal exposure. Inflamm Bowel Dis. 2017;23(4):561\u20139. https:\/\/doi.org\/10.1097\/MIB.0000000000001064 .","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"172_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bpg.2007.06.002","volume":"21","author":"U Mahadevan","year":"2007","unstructured":"Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol. 2007;21(5):849\u201377. https:\/\/doi.org\/10.1016\/j.bpg.2007.06.002 .","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"172_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/gast.2003.50014","volume":"124","author":"A Francella","year":"2003","unstructured":"Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124(1):9\u201317. https:\/\/doi.org\/10.1053\/gast.2003.50014 .","journal-title":"Gastroenterology"},{"issue":"5","key":"172_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.contraception.2013.12.016","volume":"89","author":"LM Gawron","year":"2014","unstructured":"\u2022 Gawron LM, Gawron AJ, Kasper A, Hammond C, Keefer L. Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey. Contraception. 2014;89(5):419\u201325. This survey study revealed that 23% of women with IBD who were at risk for pregnancy did not use any form of contraception and that only 17% used highly effective methods such as an intrauterine device. https:\/\/doi.org\/10.1016\/j.contraception.2013.12.016 .","journal-title":"Contraception"},{"key":"172_CR35","first-page":"1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"\u2022\u2022 Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65:1. Long term reversible contraception and progestin only contraceptives are the preferred method of contraception in women with IBD","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"172_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.contraception.2010.02.012","volume":"82","author":"LB Zapata","year":"2010","unstructured":"Zapata LB, Paulen ME, Cansino C, Marchbanks PA, Curtis KM. Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception. 2010;82(1):72\u201385. https:\/\/doi.org\/10.1016\/j.contraception.2010.02.012 .","journal-title":"Contraception"},{"issue":"10","key":"172_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/MIB.0000000000000134","volume":"20","author":"LM Gawron","year":"2014","unstructured":"\u2022 Gawron LM, Goldberger A, Gawron AJ, Hammond C, Keefer L. The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(10):1729\u201333. Nearly 20% of women with IBD reported improved GI symptoms related to menses while on OCPs. https:\/\/doi.org\/10.1097\/MIB.0000000000000134 .","journal-title":"Inflamm Bowel Dis"},{"key":"172_CR38","doi-asserted-by":"publisher","unstructured":"Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, et al. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol. 2013;122(2 Pt 1):380\u20139. https:\/\/doi.org\/10.1097\/AOG.0b013e3182994c43 .","DOI":"10.1097\/AOG.0b013e3182994c43"},{"key":"172_CR39","doi-asserted-by":"publisher","unstructured":"Yuhara H, Steinmaus C, Corley D, Koike J, Igarashi M, Suzuki T, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(10):953\u201362. https:\/\/doi.org\/10.1111\/apt.12294 .","DOI":"10.1111\/apt.12294"},{"issue":"9","key":"172_CR40","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103(9):2272\u201380. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02052.x .","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"172_CR41","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/MIB.0000000000000800","volume":"22","author":"CC Cotton","year":"2016","unstructured":"\u2022 Cotton CC, Baird D, Sandler RS, Long MD. Hormonal contraception use is common among patients with inflammatory bowel diseases and elevated risk for deep vein thrombosis. Inflamm Bowel Dis. 2016;22(7):1631\u20138. Nearly one third of women surveyed were on hormonal contraception even despite elevated risk of deep vein thrombosis. https:\/\/doi.org\/10.1097\/MIB.0000000000000800 .","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"172_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0016-5085(98)70419-6","volume":"114","author":"A Timmer","year":"1998","unstructured":"Timmer A, Sutherland LR, Martin F. The Canadian Mesalamine for remission of Crohn\u2019s disease study group. Oral contraceptive use and smoking are risk factors for relapse in Crohn\u2019s disease. Gastroenterology. 1998;114(6):1143\u201350. https:\/\/doi.org\/10.1016\/S0016-5085(98)70419-6 .","journal-title":"Gastroenterology"},{"issue":"2","key":"172_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/gut.45.2.218","volume":"45","author":"J Cosnes","year":"1999","unstructured":"Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn\u2019s disease: a prospective cohort study. Gut. 1999;45(2):218\u201322. https:\/\/doi.org\/10.1136\/gut.45.2.218 .","journal-title":"Gut"},{"issue":"9","key":"172_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/BF01296007","volume":"37","author":"LR Sutherland","year":"1992","unstructured":"Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of oral contraceptive use on reoperation following surgery for Crohn\u2019s disease. Dig Dis Sci. 1992;37(9):1377\u201382. https:\/\/doi.org\/10.1007\/BF01296007 .","journal-title":"Dig Dis Sci"},{"key":"172_CR45","doi-asserted-by":"publisher","unstructured":"Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120(1):13\u201320. https:\/\/doi.org\/10.1053\/gast.2001.20912 .","DOI":"10.1053\/gast.2001.20912"},{"issue":"9","key":"172_CR46","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","volume":"103","author":"JA Cornish","year":"2008","unstructured":"Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103(9):2394\u2013400. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02064.x .","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"172_CR47","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/MEG.0000000000000915","volume":"29","author":"R Ortizo","year":"2017","unstructured":"\u2022 Ortizo R, Lee SY, Nguyen, et al. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies. Eur J Gastroenterol Hepatol. 2017;29(9):1064\u201370. This meta-analysis of 20 studies showed an increased risk of 30% for the development of UC and an increased risk of 24% for the development of CD in those who were exposed to OCPs. https:\/\/doi.org\/10.1097\/MEG.0000000000000915 .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"172_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","volume":"73","author":"KM Curtis","year":"2006","unstructured":"Curtis KM, Martins SL. Progestogen-only contraception and bone mineral density: a systematic review. Contraception. 2006;73(5):470\u201387. https:\/\/doi.org\/10.1016\/j.contraception.2005.12.010 .","journal-title":"Contraception"},{"issue":"7","key":"172_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","volume":"122","author":"T Ali","year":"2009","unstructured":"Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122(7):599\u2013604. https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.022 .","journal-title":"Am J Med"},{"issue":"3","key":"172_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1783\/147118903101197548","volume":"29","author":"J Wakeman","year":"2003","unstructured":"Wakeman J. Exacerbation of Crohn\u2019s disease after insertion of a levonorgestrel intrauterine system: a case report. J Fam Plann Reprod Health Care. 2003;29(3):154. https:\/\/doi.org\/10.1783\/147118903101197548 .","journal-title":"J Fam Plann Reprod Health Care."},{"issue":"2","key":"172_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1783\/147118902101196225","volume":"28","author":"M Cox","year":"2002","unstructured":"Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK family planning and reproductive health research network: 5-year report. J Fam Plann Reprod Health Care. 2002;28(2):73\u20137. https:\/\/doi.org\/10.1783\/147118902101196225 .","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"3","key":"172_CR52","doi-asserted-by":"publisher","first-page":"521534","DOI":"10.1016\/j.mcna.2015.01.006","volume":"99","author":"TA Takahashi","year":"2015","unstructured":"\u2022 Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015;99(3):521534. This study reviewed demographics of menopause in women with IBD.","journal-title":"Med Clin North Am"},{"issue":"267","key":"172_CR53","first-page":"623","volume":"72","author":"A Lichtarowicz","year":"1989","unstructured":"Lichtarowicz A, Norman C, Calcraft B, Morris JS, Rhodes J, Mayberry J. A study of the menopause, smoking, and contraception in women with Crohn's disease. Q J Med. 1989;72(267):623\u201331.","journal-title":"Q J Med"},{"issue":"5","key":"172_CR54","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1572-0241.2007.01700.x","volume":"103","author":"SV Kane","year":"2008","unstructured":"Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1193\u20136. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01700.x .","journal-title":"Am J Gastroenterol"},{"key":"172_CR55","doi-asserted-by":"crossref","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial. J Am Med Assoc. 2002;288(3):321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"issue":"5","key":"172_CR56","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1053\/j.gastro.2012.07.096","volume":"43","author":"H Khalili","year":"2012","unstructured":"Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Hormone therapy increases risk of ulcerative colitis but not Crohn\u2019s disease. Gastroenterology. 2012;43(5):1199\u2013206.","journal-title":"Gastroenterology"},{"issue":"1","key":"172_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cgh.2006.10.018","volume":"5","author":"A Timmer","year":"2007","unstructured":"Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol. 2007;5(1):87\u201394. https:\/\/doi.org\/10.1016\/j.cgh.2006.10.018 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"172_CR58","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/00000658-198612000-00002","volume":"204","author":"A Metcalf","year":"1986","unstructured":"Metcalf A, Dozois R, Kelly A. Sexual function in women after proctocolectomy. Ann Surg. 1986;204(6):624\u20137. https:\/\/doi.org\/10.1097\/00000658-198612000-00002 .","journal-title":"Ann Surg"},{"issue":"2","key":"172_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1010625806500","volume":"19","author":"P Weerakoon","year":"2001","unstructured":"Weerakoon P. Sexuality and the patient with a stoma. Sex Disabil. 2001;19(2):121\u20139. https:\/\/doi.org\/10.1023\/A:1010625806500 .","journal-title":"Sex Disabil"},{"issue":"4","key":"172_CR60","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ibd.21090","volume":"16","author":"KR Muller","year":"2010","unstructured":"Muller KR, Prosser R, Bampton P, Mountifield R, Andrews JM. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16(4):657\u201363. https:\/\/doi.org\/10.1002\/ibd.21090 .","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"172_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ibd.20955","volume":"16","author":"ML Borum","year":"2010","unstructured":"Borum ML, Igiehon E, Shafa S. Physicians may inadequately address sexuality in women with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(2):181. https:\/\/doi.org\/10.1002\/ibd.20955 .","journal-title":"Inflamm Bowel Dis"},{"key":"172_CR62","doi-asserted-by":"publisher","unstructured":"Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women\u2019s interagency HIV study group. J Acquir Immune Defic Syndr. 1999;21(1):33\u201341. https:\/\/doi.org\/10.1097\/00126334-199905010-00005 .","DOI":"10.1097\/00126334-199905010-00005"},{"key":"172_CR63","volume-title":"ACOG guidelines for womens health care","author":"American College of Obstetricians and Gynecologists","year":"2014","unstructured":"\u2022\u2022 American College of Obstetricians and Gynecologists. ACOG guidelines for womens health care. Washington, DC: The College; 2014. Updated from 2010, this document provides guidance on a wide variety of womens health issues."},{"issue":"2","key":"172_CR64","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ogc.2013.02.005","volume":"40","author":"ML Nguyen","year":"2013","unstructured":"Nguyen ML, Flowers L. Cervical cancer screening in immunocompromised women. Obstet Gynecol Clin N Am. 2013 Jun;40(2):339\u201357. https:\/\/doi.org\/10.1016\/j.ogc.2013.02.005 .","journal-title":"Obstet Gynecol Clin N Am"},{"key":"172_CR65","doi-asserted-by":"publisher","unstructured":"Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12(38):6167\u201371. https:\/\/doi.org\/10.3748\/wjg.v12.i38.6167 .","DOI":"10.3748\/wjg.v12.i38.6167"},{"issue":"3","key":"172_CR66","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","volume":"103","author":"S Kane","year":"2008","unstructured":"Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(3):631\u20136. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01582.x .","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"172_CR67","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S Sanjose De","year":"2010","unstructured":"De Sanjose S, Quint G, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8 .","journal-title":"Lancet Oncol"},{"key":"172_CR68","doi-asserted-by":"publisher","unstructured":"Lees CW, Critchley J, Chee N, Beez T, Gailer RE, Williams AR, et al. Lack of association between cervical dysplasia and IBD: a large case-control study. Inflamm Bowel Dis. 2009;15(11):1621\u20139. https:\/\/doi.org\/10.1002\/ibd.20959 .","DOI":"10.1002\/ibd.20959"},{"issue":"2","key":"172_CR69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","volume":"136","author":"H Singh","year":"2009","unstructured":"Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology. 2009;136(2):451\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.021 .","journal-title":"Gastroenterology"},{"issue":"4","key":"172_CR70","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","volume":"13","author":"C Rungoe","year":"2015","unstructured":"\u2022 Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol. 2015;13(4):693\u2013700.e691. This is a population-based cohort of nearly 30,000 women with IBD which reported increased risk for cervical dysplasia in women with IBD and increased risk of cervical cancer in those with CD. https:\/\/doi.org\/10.1016\/j.cgh.2014.07.036 .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"27","key":"172_CR71","doi-asserted-by":"publisher","first-page":"e4012","DOI":"10.1097\/MD.0000000000004012","volume":"95","author":"N Pandey","year":"2016","unstructured":"\u2022 Pandey N, Herrera HH, Johnson CM, MacCarthy AA, Copeland l. Preventative Care for Patients with inflammatory bowel disease in the veterans health administration. Medicine. 2016;95(27):e4012. Retrospective study performed at the Veteran\u2019s Health Administration showed that among women under 65 years of age with IBD, 15% had abnormal Pap smears compared to 5% among normal patient population. https:\/\/doi.org\/10.1097\/MD.0000000000004012 .","journal-title":"Medicine"},{"issue":"4","key":"172_CR72","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/AOG.0000000000001708","volume":"128","author":"Bulletins\u2014Gynecology CoP","year":"2016","unstructured":"\u2022 Bulletins\u2014Gynecology CoP. ACOG practice bulletin number 157: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):111\u201330. This practice bulletin provides the most recent guidance on cervical cancer screening.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"172_CR73","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ibd.20944","volume":"15","author":"M Moscandrew","year":"2009","unstructured":"Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009;15(9):1399\u2013409. https:\/\/doi.org\/10.1002\/ibd.20944 .","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"172_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajg.2016.537","volume":"112","author":"F Farraye","year":"2017","unstructured":"\u2022\u2022 Farraye F, Melmed G, Lichtenstein R, et al. ACG clinical guideline: preventitive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241\u201358. This ACG clinical guidelines for preventitive care recommends yearly Pap smears in women who are on immunosupressive treatments. https:\/\/doi.org\/10.1038\/ajg.2016.537 .","journal-title":"Am J Gastroenterol"},{"key":"172_CR75","first-page":"1","volume":"63","author":"LE Markowitz","year":"2014","unstructured":"\u2022 Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep. 2014;63:1\u201330. This guideline recommends HPV vaccination for females aged 9 to 26.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"12","key":"172_CR76","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/ibd.21667","volume":"17","author":"SK Wasan","year":"2011","unstructured":"Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17(12):2536\u201340. https:\/\/doi.org\/10.1002\/ibd.21667 .","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-018-0172-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:39:32Z","timestamp":1570826372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-018-0172-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1007\/s11938-018-0172-4","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"26 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nirupama Bonthala declares no conflict of interest.Sunanda Kane has received consulting fees (paid to her institution) from AbbVie, Janssen, and Spherix Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}